SC 13G/A | 2009-02-17 | D. E. Shaw Valence Portfolios, L.L.C. | ARRAY BIOPHARMA INC | 1,620,091 | 3.4% | EDGAR |
SC 13G/A | 2009-02-13 | Flynn James E | ARRAY BIOPHARMA INC | 7,580,680 | 10.0% | EDGAR |
SC 13G/A | 2009-02-13 | Capital Research Global Investors | ARRAY BIOPHARMA INC | 3,615,000 | 7.6% | EDGAR |
SC 13G/A | 2009-02-05 | COLUMBIA WANGER ASSET MANAGEMENT LP | ARRAY BIOPHARMA INC | 4,065,000 | 8.5% | EDGAR |
SC 13G | 2009-02-05 | BARCLAYS GLOBAL INVESTORS NA /CA/ | ARRAY BIOPHARMA INC | 1,225,186 | 2.6% | EDGAR |
SC 13G | 2008-02-21 | D. E. Shaw Valence Portfolios, L.L.C. | ARRAY BIOPHARMA INC | 2,430,107 | 5.0% | EDGAR |
SC 13G/A | 2008-02-14 | FMR LLC | ARRAY BIOPHARMA INC | 5,036,374 | 10.7% | EDGAR |
SC 13G/A | 2008-02-14 | WELLINGTON MANAGEMENT CO LLP | ARRAY BIOPHARMA INC | 1,378,281 | 2.9% | EDGAR |
SC 13G/A | 2008-02-14 | Flynn James E | ARRAY BIOPHARMA INC | 1,667,942 | 3.5% | EDGAR |
SC 13G | 2008-02-12 | Capital Research Global Investors | ARRAY BIOPHARMA INC | 2,740,000 | 5.8% | EDGAR |
SC 13G/A | 2008-01-24 | COLUMBIA WANGER ASSET MANAGEMENT LP | ARRAY BIOPHARMA INC | 4,175,000 | 8.9% | EDGAR |
SC 13G/A | 2008-01-04 | KOPP INVESTMENT ADVISORS LLC | ARRAY BIOPHARMA INC | 1,488,405 | 3.2% | EDGAR |
SC 13G/A | 2007-10-22 | ORBIMED ADVISORS LLC | ARRAY BIOPHARMA INC | 210,100 | 0.4% | EDGAR |
SC 13G | 2007-06-11 | FMR CORP | ARRAY BIOPHARMA INC | 4,806,500 | 10.2% | EDGAR |
SC 13G/A | 2007-02-14 | WELLINGTON MANAGEMENT CO LLP | ARRAY BIOPHARMA INC | 2,302,421 | 5.9% | EDGAR |
SC 13G/A | 2007-02-13 | Flynn James E | ARRAY BIOPHARMA INC | 1,022,307 | 2.6% | EDGAR |
SC 13G/A | 2007-02-09 | ORBIMED ADVISORS LLC | ARRAY BIOPHARMA INC | 895,300 | 2.3% | EDGAR |
SC 13G/A | 2007-01-18 | KOPP INVESTMENT ADVISORS LLC | ARRAY BIOPHARMA INC | 2,599,010 | - | EDGAR |
SC 13G | 2007-01-11 | COLUMBIA WANGER ASSET MANAGEMENT LP | ARRAY BIOPHARMA INC | 2,172,000 | 5.5% | EDGAR |
SC 13G/A | 2006-12-11 | WELLINGTON MANAGEMENT CO LLP | ARRAY BIOPHARMA INC | 2,440,721 | 6.2% | EDGAR |